Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Consensus Rating of Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Brokerages Set Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) PT at $54 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $65.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 123.91% from the stock’s previous close. […]
Analysts Set Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Target Price at $54 80 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald in a report released on Wednesday, Benzinga reports. They presently have a $65.00 price objective on the biotechnology company’s stock. Cantor Fitzgerald’s target price points to a potential upside of 122.76% from the stock’s current price. Several […]